These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8217795)

  • 1. Occurrence of point mutations in p53 gene is not increased in patients with acute myeloid leukaemia carrying an activating N-ras mutation.
    Bühler-Leclerc M; Gratwohl A; Senn HP
    Br J Haematol; 1993 Jul; 84(3):443-50. PubMed ID: 8217795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of conservative RAS mutations in acute myeloid leukemia.
    Aurer I; Labar B; Nemet D; Ajduković R; Bogdanić V; Gale RP
    Acta Haematol; 1994; 92(3):123-5. PubMed ID: 7871950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular study on minute alterations of the p53 and the N-ras genes in hematologic malignancies].
    Kurosawa M
    Hokkaido Igaku Zasshi; 1994 May; 69(3):543-54. PubMed ID: 7927179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemia.
    Kubo K; Naoe T; Kiyoi H; Fukutani H; Kato Y; Oguri T; Yamamori S; Akatsuka Y; Kodera Y; Ohno R
    Jpn J Cancer Res; 1993 Apr; 84(4):379-87. PubMed ID: 8514604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia.
    Nakagawa T; Saitoh S; Imoto S; Itoh M; Tsutsumi M; Hikiji K; Nakamura H; Matozaki S; Ogawa R; Nakao Y
    Oncology; 1992; 49(2):114-22. PubMed ID: 1574246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of the ras gene in myelocytic leukemia by polymerase chain reaction and oligonucleotide probes.
    Liu TC; Lin SF; Chen TP; Liu HW; Chang JG
    J Formos Med Assoc; 1991 Sep; 90(9):825-30. PubMed ID: 1683380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Lu D; Nounou R; Beran M; Estey E; Manshouri T; Kantarjian H; Keating MJ; Albitar M
    Cancer; 2003 Jan; 97(2):441-9. PubMed ID: 12518368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of the P53 gene in acute myeloid leukaemia.
    Fenaux P; Preudhomme C; Quiquandon I; Jonveaux P; Laï JL; Vanrumbeke M; Loucheux-Lefebvre MH; Bauters F; Berger R; Kerckaert JP
    Br J Haematol; 1992 Feb; 80(2):178-83. PubMed ID: 1550773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic mutations of p53 and k-ras in gastric carcinoma patients from Hunan, China.
    Chen HC; Chen HJ; Khan MA; Rao ZZ; Wan XX; Tan B; Zhang DZ
    Tumour Biol; 2011 Apr; 32(2):367-73. PubMed ID: 21080251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-fms point mutations in acute myeloid leukemia: fact or fiction?
    Springall F; O'Mara S; Shounan Y; Todd A; Ford D; Iland H
    Leukemia; 1993 Jul; 7(7):978-85. PubMed ID: 8321048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia.
    Vasioukhin V; Anker P; Maurice P; Lyautey J; Lederrey C; Stroun M
    Br J Haematol; 1994 Apr; 86(4):774-9. PubMed ID: 7918071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras oncogene and p53 gene hotspot mutations in colorectal cancers.
    Lin SY; Chen PH; Yang MJ; Chen TC; Chang CP; Chang JG
    J Gastroenterol Hepatol; 1995; 10(2):119-24. PubMed ID: 7787154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ras oncogene activation and occupational exposures in acute myeloid leukemia.
    Taylor JA; Sandler DP; Bloomfield CD; Shore DL; Ball ED; Neubauer A; McIntyre OR; Liu E
    J Natl Cancer Inst; 1992 Nov; 84(21):1626-32. PubMed ID: 1433344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutation in the myelodysplastic syndromes.
    Adamson DJ; Dawson AA; Bennett B; King DJ; Haites NE
    Br J Haematol; 1995 Jan; 89(1):61-6. PubMed ID: 7833278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of ras gene activation in myeloid leukemic cells.
    Lübbert M; Jonas D; Miller CW; Herrmann F; Mertelsmann R; McCormick F; Koeffler HP
    Oncogene; 1990 Apr; 5(4):583-7. PubMed ID: 2183160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
    Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
    Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of ras gene mutations in childhood myeloid leukaemia.
    Farr C; Gill R; Katz F; Gibbons B; Marshall CJ
    Br J Haematol; 1991 Mar; 77(3):323-7. PubMed ID: 2012756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutations in sporadic adrenocortical tumors.
    Ohgaki H; Kleihues P; Heitz PU
    Int J Cancer; 1993 May; 54(3):408-10. PubMed ID: 8509216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
    Lang SM; Heinzlmann M; Stratakis DF; Teschauer W; Loeschke K
    Am J Gastroenterol; 1997 Dec; 92(12):2166-70. PubMed ID: 9399746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia.
    Shih LY; Huang CF; Wang PN; Wu JH; Lin TL; Dunn P; Kuo MC
    Leukemia; 2004 Mar; 18(3):466-75. PubMed ID: 14737077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.